SCHEMBL19424137

SCHEMBL19424137

COc1ccc(C(C)=O)c(SC)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.61
▸ HPGD P15428 4/20 0.61
▸ CYP3A4 P08684 2/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ RAB9A P51151 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ KMT2A Q03164 6/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAOB P27338 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ MAPT P10636 3/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ LMNA P02545 1/20 0.42
▸ PGR P06401 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42
▸ AR P10275 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11175864 0.87 ALDH1A1 (0.62) ALDH1A1HPGDCYP3A4MAPK1RAB9A
SCHEMBL8470680 0.79 HPGD (0.53) ALDH1A1HPGDCYP3A4MAPK1RAB9A
SCHEMBL11761193 0.79 ALDH1A1 (0.66) ALDH1A1HPGDCYP3A4MAPK1RAB9A
SCHEMBL13094612 0.79 ALDH1A1 (0.71) ALDH1A1HPGDCYP3A4MAPK1RAB9A
SCHEMBL7080954 0.78 ALDH1A1 (0.51) ALDH1A1HPGDCYP3A4MAPK1RAB9A
SCHEMBL8640585 0.78 SMN1; SMN2 (0.59) ALDH1A1HPGDCYP3A4RAB9ANPC1
SCHEMBL2975263 0.78 KMT2A (0.47) ALDH1A1HPGDCYP3A4MAPK1RAB9A
SCHEMBL7681445 0.77 KMT2A (0.59) ALDH1A1HPGDCYP3A4MAPK1RAB9A
SCHEMBL8636977 0.76 TUBB1 (0.49) ALDH1A1HPGDCYP3A4MAPK1KMT2A
SCHEMBL8636973 0.76 TUBB1 (0.49) ALDH1A1HPGDCYP3A4MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795563-B1 INDOLINE ANALOGS AND USES THEREOF ONCTERNAL THERAPEUTICS INC (US) 2024-07-17 — — EP disclosed
EP-3795563-A1 INDOLINE ANALOGS AND USES THEREOF Oncternal Therapeutics, Inc. (US) 2021-03-24 — — EP disclosed
EP-3436434-B1 INDOLINE ANALOGS AND USES THEREOF ONCTERNAL THERAPEUTICS INC (US) 2020-07-08 — — EP disclosed
US-10351569-B2 Indoline analogs and uses thereof Oncternal Therapeutics, Inc. (US) 2019-07-16 — — US disclosed
US-20170349600-A1 INDOLINE ANALOGS AND USES THEREOF GEORGETOWN UNIVERSITY 2017-12-07 — — US disclosed
US-9822122-B2 Indoline analogs and uses thereof Oncternal Therapeutics, Inc. (US) 2017-11-21 — — US disclosed
WO-2017172368-A1 INDOLINE ANALOGS AND USES THEREOF Oncternal Therapeutics, Inc. (US) 2017-10-05 — — WO disclosed
US-20170283420-A1 INDOLINE ANALOGS AND USES THEREOF GEORGETOWN UNIVERSITY 2017-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351569-B2 Indoline analogs and uses thereof FLI1, EWSR1, IKZF1 ALDH1A1 2456/4885HPGD 3906/4885CYP3A4 4054/4885
US-20170283420-A1 INDOLINE ANALOGS AND USES THEREOF FLI1, EWSR1, IKZF1 ALDH1A1 2456/4885HPGD 3906/4885CYP3A4 4054/4885
US-20170349600-A1 INDOLINE ANALOGS AND USES THEREOF FLI1, EWSR1, IKZF1 ALDH1A1 2456/4885HPGD 3906/4885CYP3A4 4054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback